Results 161 to 170 of about 44,475 (230)

CXCL12 and eotaxin are independent prognostic serum biomarkers in gastric cancer. [PDF]

open access: yesSci Rep
Brodkin J   +8 more
europepmc   +1 more source

L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy and bevacizumab in newly-diagnosed glioblastoma: expansion of the phase I/II GLORIA trial. [PDF]

open access: yesNat Commun
Giordano FA   +30 more
europepmc   +1 more source

TCF1+CD4+ T cells and microglia co-orchestrate tertiary lymphoid structures to enhance prognosis and immunotherapy in non-small cell lung cancer with brain metastases. [PDF]

open access: yesEBioMedicine
Yu Q   +14 more
europepmc   +1 more source

HIV-1 envelope glycoprotein modulates CXCR4 clustering and dynamics on the T cell membrane. [PDF]

open access: yesElife
Quijada-Freire A   +15 more
europepmc   +1 more source

From complexity to clarity: aging bone marrow niche in bone and blood regeneration and malignancy. [PDF]

open access: yesBone Res
Roy N   +9 more
europepmc   +1 more source

Multi-omics reveals CXCR4 drives immune escape in colorectal cancer via metabolic reprogramming and immune microenvironment remodeling. [PDF]

open access: yesCell Death Dis
Zhu C   +12 more
europepmc   +1 more source

Acquired nonpermissive BM microenvironment impairs HSC proliferation and maintenance, and B-cell development after HSCT. [PDF]

open access: yesBlood Adv
de Gier M   +16 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy